FilingIndex
← The Wire
ARMPNYSE

Armata Pharmaceuticals, Inc.

Biological Products, (No Diagnostic Substances) · WA · CIK 921114

Develops bacteriophage therapeutics for antibiotic-resistant bacterial infections

red 8-K · 90d
$278M
Market cap
$6.46
Last close
-12.7%
1D
-6.0%
5D
235K
Volume
Price · last 39 sessions-34.4%
May 4L $6.46 · H $9.85Jun 29
466
Total filings
Jun 24, 2026
Last filing
12/31
Fiscal year end
8-K/AExecutive ChangeJun 24, 20268-KCompany UpdateJun 23, 20268-KShareholder VoteJun 16, 202610-Q10-QMay 13, 20268-KMaterial Agreement · Results of OperationsMay 13, 2026SC 13D/ASC 13D/AMay 13, 20268-KReg FD DisclosureMay 7, 2026DEF 14ADEF 14AApr 27, 20268-KExecutive Change · Reg FD DisclosureApr 27, 20268-KCompany UpdateApr 2, 202610-K10-KMar 25, 20268-KResults of OperationsMar 25, 20268-KReg FD DisclosureMar 19, 20268-KReg FD DisclosureFeb 23, 20268-KMaterial AgreementJan 26, 2026SC 13D/ASC 13D/AJan 26, 20268-KReg FD DisclosureJan 13, 20268-KMaterial AgreementDec 1, 2025424B5424B5Dec 1, 202510-Q10-QNov 12, 20258-KResults of OperationsNov 12, 20258-KReg FD DisclosureOct 22, 20258-KReg FD DisclosureSep 11, 202510-Q10-QAug 12, 20258-KMaterial Agreement · Results of OperationsAug 12, 20258-KShareholder VoteJun 13, 20258-KReg FD DisclosureMay 19, 202510-Q10-QMay 14, 20258-KResults of OperationsMay 14, 20258-KCompany UpdateMay 1, 2025DEF 14AFORM DEF 14AApr 28, 20258-KCompany UpdateApr 2, 202510-K10-KMar 21, 20258-KResults of OperationsMar 21, 20258-KMaterial Agreement · New Debt / ObligationMar 12, 20258-KReg FD DisclosureDec 19, 20248-KExecutive ChangeDec 4, 20248-KExecutive Change · Material AgreementNov 15, 202410-Q10-QNov 13, 20248-KResults of OperationsNov 13, 20248-KReg FD DisclosureNov 12, 20248-KExecutive ChangeOct 3, 20248-KExecutive ChangeSep 26, 20248-KReg FD DisclosureAug 26, 20248-KExecutive ChangeAug 15, 202410-Q10-QAug 13, 20248-KResults of OperationsAug 13, 20248-KExecutive ChangeJul 25, 20248-KShareholder VoteJun 14, 202410-Q10-QMay 7, 20248-KResults of OperationsMay 7, 2024DEF 14ADEF 14AApr 29, 20248-KCompany UpdateMar 22, 202410-K10-KMar 21, 20248-KResults of OperationsMar 21, 20248-KMaterial Agreement · New Debt / ObligationMar 4, 202410-Q10-QNov 14, 20238-KResults of OperationsNov 14, 20238-KExecutive Change · Shareholder VoteSep 20, 202310-Q10-QAug 14, 20238-KResults of OperationsAug 14, 2023DEFA14ADEFA14AAug 3, 2023DEF 14ADEF 14AAug 3, 20238-KExecutive ChangeJul 19, 20238-KExecutive Change · Material AgreementJul 11, 20238-KResults of Operations · Company UpdateJun 27, 20238-KResults of OperationsMay 12, 202310-Q10-QMay 11, 20238-KExecutive ChangeMay 5, 20238-KResults of OperationsMar 16, 202310-K10-KMar 16, 20238-KReg FD DisclosureMar 6, 20238-KMaterial Agreement · New Debt / ObligationJan 10, 20238-KExecutive ChangeDec 19, 20228-KShareholder VoteNov 18, 20228-KResults of OperationsNov 9, 202210-Q10-QNov 9, 2022DEF 14ADEF 14AOct 17, 20228-KResults of Operations · Company UpdateSep 20, 20228-KResults of OperationsAug 11, 2022

Similar companies

Comparable business profile · signals at a glance